Author:
Kamble Srushti,Yadav Gangotri,Jain Ashish
Abstract
Background: Microsponges are porous, polymeric microspheres employed for sustained topical treatment. They may modify the release pattern, lessen adverse effects, and improve stability. Terbinafine HCL is a fungicidal allylamine derivative with a wide range of antifungal activity. It is used to treat various skin disorders like ringworm, athlete’s foot, and jock itch.
Objective: The aim of the current study focuses on the development of terbinafine HCL microsponges that will release the drug in a sustained pattern to prevent side effects and then put those microsponges into a gel.
Method: The quasi-emulsion solvent diffusion method was employed to develop Microsponges by using various drug: polymer ratios.
Result: The results of the FTIR spectra showed that there was an absence of interaction between Terbinafine HCL and the excipients. Based on the evaluation parameter, it was found that batch MS3 showed the highest entrapment efficiency of 86.32%. Polymer EC showed better results. Microsponges and Microsponges gel showed sustained release of drug till 8 and 10 hours, respectively. The gels were shown to be stable throughout a wide temperature range, according to the stability studies.
Conclusion: It was concluded that the Microsponges release the drug in a stained manner. The production process for microsponge technology has the potential to improve patient compliance with terbinafine hydrochloride microsponge gel.
Publisher
BSP Books Private Limited
Reference20 articles.
1. Choudhary SV, Bisati S, Singh AL, Koley S. Efficacy and safety of terbinafine hydrochloride 1% cream vs. sertaconazole nitrate 2% cream in tinea corporis and tinea cruris: A comparative therapeutic trial. Indian J Dermatol [Internet]. 2013;58(6):457.
2. Malcolm JM, Darkes LJ, Scott KL. Terbinafine: a review of its use in onychomycosis in adults. American Journal of Clinical Dermatology. 2003;4(1):39–65.
3. Joshi G, Kaur R, Kaur H. Microsponges: a novel drug delivery system. International Research Journal of Pharmaceutical and Biosciences. 2016;3(1):1–11.
4. Ingale DJ, Aloorkar NH, KulkarnI AS, Patil RAP. Microsponges as innovative drug delivery systems. PCI- Approved-IJPSN [Internet]. 2012;5(1):1597–606.
5. Charde MS, Ghanawat PB, Welankiwar AS, Kumar J, Chakole RD. Microsponge: a Novel New Drug Delivery System: A Review. International Journal of Advances in Pharmaceutics. 2013;2(6).